Earlier age of dementia onset and shorter survival times in dementia patients with diabetes

American Journal of Epidemiology

Volumn 177, Issue 11, 2013, Pages 1246-1254

  Zilkens, R R ^a   Davis, W A ^b   Spilsbury, K ^b   Semmens, J B ^b   Bruce, D G ^b  

^a CURTIN UNIVERSITY   (Australia)

^b NONE

Author keywords

Alzheimer disease; dementia; diabetes mellitus; mortality; proportional hazards models; retrospective studies; survival

Indexed keywords

DIABETES; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE PREVALENCE; DISEASE SEVERITY; DISEASE TREATMENT; EPIDEMIOLOGY; HEALTH RISK; POPULATION STRUCTURE; RISK FACTOR; SURVIVAL;

ADULT; AGED; ARTICLE; AUSTRALIA; COMORBIDITY; COMPARATIVE STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; ONSET AGE; POPULATION RESEARCH; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL TIME;

ALZHEIMER DISEASE; DEMENTIA; DIABETES MELLITUS; MORTALITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; COHORT STUDIES; DEMENTIA; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; WESTERN AUSTRALIA;

AUSTRALIA; WESTERN AUSTRALIA;

EID: 84878541187     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws387     Document Type: Article

References (54)

1. Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64-74.
2. XuW, Qiu C, Gatz M, et al. Mid-and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes. 2009;58(1):71-77.
3. Schnaider Beeri M, Goldbourt U, Silverman JM, et al. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology. 2004;63(10):1902-1907.
4. Cukierman T, Gerstein HC,Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia. 2005;48(12):2460-2469.
5. Whitmer RA, Sidney S, Selby J, et al. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64(2):277-281.
6. Velayudhan L, Poppe M, Archer N, et al. Risk of developing dementia in people with diabetes and mild cognitive impairment. Br J Psychiatry. 2010;196(1):36-40.
7. Chittleborough CR, Grant JF, Phillips PJ, et al. The increasing prevalence of diabetes in South Australia: the relationship with population ageing and obesity. Public Health. 2007;121(2): 92-99.
8. Gonzalez EL, Johansson S,Wallander MA, et al. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health. 2009;63(4):332-336.
9. Boston PF, Dennis MS, Jagger C. Factors associated with vascular dementia in an elderly community population. Int J Geriatr Psychiatry. 1999;14(9):761-766.
10. Ott A, Stolk RP, Hofman A, et al. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia. 1996;39(11):1392-1397.
11. MacKnight C, Rockwood K, Awalt E, et al. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord. 2002;14(2): 77-83.
12. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology. 1995;45(6):1161-1168.
13. Hassing LB, Johansson B, Nilsson SE, et al. Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old. Int Psychogeriatr. 2002;14(3):239-248.
14. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes. 2002;51(4): 1256-1262.
15. Luchsinger JA, Tang MX, Stern Y, et al. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001;154(7): 635-641.
16. Arvanitakis Z,Wilson RS, Bienias JL, et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004;61(5):661-666.
17. Brayne C, Gill C, Huppert FA, et al. Vascular risks and incident dementia: results from a cohort study of the very old. Dement Geriatr Cogn Disord. 1998;9(3):175-180.
18. Luchsinger JA, Reitz C, Honig LS, et al. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology. 2005;65(4):545-551.
19. Yamada M, Kasagi F, Sasaki H, et al. Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J Am Geriatr Soc. 2003;51(3):410-414.
20. Imfeld P, Bodmer M, Jick SS, et al. Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study. J Am Geriatr Soc. 2012;60(5):916-921.
21. Leibson CL, RoccaWA, Hanson VA, et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol. 1997;145(4):301-308.
22. Regan C, Katona C,Walker Z, et al. Relationship of vascular risk to the progression of Alzheimer disease. Neurology. 2006;67(8):1357-1362.
23. Helzner EP, Luchsinger JA, Scarmeas N, et al. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol. 2009;66(3):343-348.
24. XuW, Caracciolo B,Wang HX, et al. Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes. 2010;59(11):2928-2935.
25. Sanz C, Andrieu S, Sinclair A, et al. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology. 2009;73(17):1359-1366.
26. Musicco M, Palmer K, Salamone G, et al. Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors. J Neurol. 2009;256(8):1288-1295.
27. Murthy SB, Jawaid A, Qureshi SU, et al. Does diabetes mellitus alter the onset and clinical course of vascular dementia? Behav Neurol. 2010;23(3):145-151.
28. Sonnen JA, Larson EB, Brickell K, et al. Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol. 2009;66(3):315-322.
29. Ahtiluoto S, Polvikoski T, Peltonen M, et al. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology. 2010;75(13):1195-1202.
30. Bosco D, Fava A, Plastino M, et al. Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis. J Cell Mol Med. 2011;15(9):1807-1821.
31. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88(9): 1337-1342.
32. Helzner EP, Scarmeas N, Cosentino S, et al. Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Neurology. 2008;71(19):1489-1495.
33. Holman CD, Bass AJ, Rouse IL, et al. Population-based linkage of health records inWestern Australia: development of a health services research linked database. Aust N Z J Public Health. 1999;23(5):453-459.
34. Holman CD, Bass AJ, Rosman DL, et al. A decade of data linkage inWestern Australia: strategic design, applications and benefits of theWA data linkage system. Aust Health Rev. 2008;32(4):766-777.
35. Brameld KJ, Thomas MA, Holman CD, et al. Validation of linked administrative data on end-stage renal failure: application of record linkage to a 'clinical base population'. Aust N Z J Public Health. 1999;23(5):464-467.
36. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5): 373-383.
37. Preen DB, Holman CD, Spilsbury K, et al. Length of comorbidity lookback period affected regression model performance of administrative health data. J Clin Epidemiol. 2006;59(9):940-946.
38. Thiebaut AC, Benichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med. 2004;23(24):3803-3820.
39. Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. Stata J. 2009;9(2): 265-290.
40. Brookmeyer R, Johnson E, Ziegler-Graham K, et al. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007;3(3):186-191.
41. Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008;7(2):184-190.
42. Chan JC, Malik V, JiaW, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129-2140.
43. Kloppenborg RP, van den Berg E, Kappelle LJ, et al. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol. 2008;585(1):97-108.
44. Fitzpatrick AL, Kuller LH, Lopez OL, et al. Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci. 2005;229-230:43-49.
45. Wandell PE. Risk factors for microvascular and macrovascular complications in men and women with type 2 diabetes. Scand J Prim Health Care. 1999;17(2):116-121.
46. Giannakopoulos P, Gold G, Kovari E, et al. Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience. Acta Neuropathol (Berl). 2007;113(1):1-12.
47. Salkovic-Petrisic M, Osmanovic J, Grunblatt E, et al. Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta. J Alzheimers Dis. 2009;18(4):729-750.
48. Takeuchi M, Yamagishi S. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease. Curr Pharm Des. 2008;14(10): 973-978.
49. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258): 405-412.
50. Phung TK, Andersen BB, Hogh P, et al. Validity of dementia diagnoses in the Danish hospital registers. Dement Geriatr Cogn Disord. 2007;24(3):220-228.
51. Henderson T, Shepheard J, Sundararajan V. Quality of diagnosis and procedure coding in ICD-10 administrative data. Med Care. 2006;44(11):1011-1019.
52. Cameron AJ, Welborn TA, Zimmet PZ, et al. Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust. 2003; 178(9):427-432.
53. Wannamethee SG, Shaper AG.Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care. 1999;22(8):1266- 1272.
54. Brayne C, Ince PG, Keage HA, et al. Education, the brain and dementia: neuroprotection or compensation? Brain. 2010; 133(pt 8):2210-2216.